Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Cannabidiol Market Forecast 2026–2030: Size, Value And Compound Annual Growth Rate
The cannabidiol market has experienced significant growth in recent years. It is anticipated to increase from $15.44 billion in 2025 to $20.34 billion in 2026, with a compound annual growth rate (CAGR) of 31.7%. Key drivers behind this historical growth include the legalization of medical cannabis in pivotal regions, an uptick in the use of alternative medicine, increased consumer understanding of CBD benefits, the proliferation of hemp cultivation, and the widespread availability of CBD extraction technologies.
The cannabidiol market size is projected to experience substantial expansion over the coming years, reaching $62.61 billion by 2030, driven by a compound annual growth rate (CAGR) of 32.5%. This anticipated growth throughout the forecast period stems from factors such as the increasing acceptance of CBD in healthcare, heightened investments in cannabinoid research, the proliferation of regulated CBD retail channels, a rising demand for plant-based therapeutics, and greater standardization of CBD formulations. Key developments expected during this timeframe involve a greater adoption of CBD-based therapeutics, an escalating demand for wellness and nutraceutical items, expanded application in personal care formulations, the broadening of pharmaceutical-grade CBD products, and an intensified emphasis on regulatory compliance.
Try Before You Buy: Free Sample Of The Cannabidiol Market Report:
Cannabidiol Market Growth Engine: The Factor Boosting Demand Globally
The growing occurrence of neurological conditions is anticipated to boost the expansion of the cannabidiol market in the future. A neurological disorder is a medical state affecting the central and peripheral nervous systems, involving the brain, spinal cord, and the body’s nerves. Cannabis aids in treating these conditions by controlling calcium homeostasis and reducing neuroinflammation. For instance, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia in 2023, a number projected to reach 13.8 million by 2060. Therefore, the increasing prevalence of neurological disorders is driving the growth of the cannabidiol market.
Which Categories And Subcategories Shape The Cannabidiol Market?
The cannabidiol market covered in this report is segmented –
1) By Product: Oil, Tinctures, Suppository, Transdermal Patches, Vape Oil, Isolates, Creams and Roll-on, Capsules, Tablet, Other Products
2) By Source: Marijuana, Hemp
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores, Other Distribution Channels
4) By Application: Medical, Personal Use, Pharmaceuticals, Wellness
Subsegments:
1) By Oil: Full-Spectrum CBD Oil, Broad-Spectrum CBD Oil, CBD Isolate Oil
2) By Tinctures: CBD Tinctures with Flavoring, Unflavored CBD Tinctures
3) By Suppository: Rectal Suppositories, Vaginal Suppositories
4) By Transdermal Patches: CBD Patches for Pain Relief, CBD Patches for Sleep
5) By Vape Oil: CBD Vape Cartridges, CBD Vape Juice
6) By Isolates: CBD Powder, CBD Crystals
7) By Creams and Roll-on: Topical CBD Creams, CBD Roll-on Gels
8) By Capsules: Softgel Capsules, Hard Capsules
9) By Tablet: CBD Tablets, CBD Chewable Tablets
10) By Other Products: Gummies, Beverages, Edibles
Cannabidiol Market Trend Insights: Strategic Focus Areas Of Leading Companies
Companies operating in the cannabidiol market are primarily focused on product innovation, such as the introduction of epilepsy therapeutics to improve seizure management. An epilepsy therapeutic launch denotes the official market debut of a pharmaceutical drug specifically formulated to prevent, manage, or treat epilepsy, with the aim of enhancing seizure control and patient outcomes. As an example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, released Clasepi for treating epilepsy. This new DCGI-approved prescription cannabidiol has been introduced in India to assist in managing seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. The synthetic CBD product has a THC content of less than 0.1%, ensuring it is non-psychotropic. Clinical studies confirm its effectiveness in reducing seizures, particularly when traditional antiseizure medications are not successful.
Leading Organizations In The Cannabidiol Market
Major companies operating in the cannabidiol market are Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte’s Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC
Continue Reading: The Full Cannabidiol Market Report:
Cannabidiol Market Regional Spotlight: Top Geography And Report Coverage
North America was the largest region in the cannabidiol market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
